Amring Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMRING PHARMS
AMRING PHARMS has four approved drugs.
Summary for Amring Pharms
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Amring Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amring Pharms | BROMFENAC SODIUM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 202030-001 | Jan 9, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Amring Pharms | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 210989-001 | Aug 22, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amring Pharms | LATANOPROST | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 200925-001 | Mar 22, 2011 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amring Pharms | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 210989-002 | Aug 22, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amring Pharms | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 078598-001 | Jan 16, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
